FGEN vs PCAR · rev $29.6M vs P/E 25, rev $33.66B
FibroGen Inc (FGEN) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
FGEN currently screens at market cap $39.3M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the FGEN and PCAR stock pages for the full models.
Not investment advice.